OQRO

Feed News

Explore

Insider trades Fund moves Congressional trades Federal contracts Screener

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

OQRO

Search/

Loading…

Director exercised or converted 56K IBRX derivative securities | OQRO

Home
Insider trades
Immunitybio
Director exercised or converted 56K IBRX derivative securities

Insider trades

Insider trade

Director exercised or converted 56K IBRX derivative securities

Traded Oct 2, 2026 · Filed Oct 6, 2026

IBRImmunitybioIBRX

56K
Derivative units

Why it stands out

Derivative exercise or conversion — not an open-market buy.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Oct 2, 2026
Reporting period: Not applicable
Filed with the SEC: Oct 6, 2026

DirectorOption exercise

Context

Classification

option exercise

Code M — exercise or conversion of a derivative security

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001326110-26-000084

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Filed / recorded

Oct 6, 2026, 10:05 PM UTC

Added to OQRO

Oct 7, 2026, 2:15 AM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

ImmunityBio, Inc.

Issuer CIK

1326110

Ticker

IBRX

Reporting person

Cheryl Cohen

Relationship

Director

Security

Stock Option (right to buy)

Table

Derivative (Table II)

Transaction date

Oct 2, 2026

Transaction code

Shares / units

55,979

Price per share

$0.00

Acquired / disposed

Disposed (D)

Shares owned after

55,979

Ownership form

Direct

Amendment

Around the same time

Director sold ~$269K of Immunitybio

Scheduled in advanceyesterday

56KShares · @ $2.98

yesterday

Derivative exercise or conversion — not an open-market buy.

More Official record

Director sold ~$851K of Immunitybio

Scheduled in advanceyesterday